New White Paper Posted August 22, 2017 State SPA Reimbursement to #340B Covered Entities Creates Disincentives to Choose the Lowest Cost Drugs https://t.co/51c8aReX3f … — Simon&Co. (@MJSimonandCo) August 22, 2017